How Much Is a Startup's Data Worth? The Complete Valuation Framework

Why your data suddenly has real value

For years, "data is the new oil" was a slogan, not a budget line. Marketing executive Clive Humby is widely credited with coining the phrase back in 2006, and it took nearly two decades, plus the rise of large language models, for the metaphor to become literally true. Today, the most valuable input to frontier AI isn't compute or talent. It's proprietary, hard-to-reproduce data. ^[6]

The public internet is being consumed faster than it grows. Epoch AI's researchers estimate the usable stock of high-quality, repetition-adjusted human-generated public text at roughly 300 trillion tokens, with a wide confidence band of 100T to 1000T, and project that on current scaling trends, language models will fully utilize that stock somewhere between 2026 and 2032, earlier if heavily over-trained. ^[8] That's not a far-off problem. For several high-value domains, it's already here.

Stanford's 2025 AI Index confirms the trajectory: model training datasets are now doubling roughly every 8 months, and training compute every 5 months. ^[6] Every doubling of dataset size has to come from somewhere, and the public web no longer supplies enough pristine, source-attributed data. The gap is being filled from one place: closed, proprietary datasets, the kind startups accumulate and, too often, delete when they shut down.

The 7 drivers that actually move the price

No single formula exists, but there's a stable set of levers that professional buyers weigh in every deal. Value isn't spread evenly across your rows: research on data Shapley values shows a small fraction of high-quality data points drives most of a model's performance, so quality and annotation can matter more than sheer size. ^[2]

• Volume (tokens or rows). The raw scale of the asset. Buyers think in tokens for text and rows for conversational/tabular data. More is better, but only past a usefulness threshold.
• Quality & annotation depth. Human-reviewed labels, outcome/resolution fields, and expert annotations multiply value because they save the buyer expensive annotation labor. ^[4]
• Domain scarcity. How few comparable public datasets exist. Legal, clinical, and finance data are scarce; generic web chatter isn't.
• Metadata richness. Structured fields such as jurisdiction, diagnosis codes, resolution status, and timestamps let buyers filter, de-duplicate, and train with far more precision.
• Recency. Data from the last 12–24 months is worth meaningfully more than older data; models need a current picture of the world.
• Licensing type. Exclusive vs. non-exclusive, perpetual vs. time-limited. This is the single biggest lever, covered next.
• Legal & compliance cleanliness. Documented consent, provenance, and de-identification. This is a gate, not a bonus: without it, reputable buyers won't touch the data at any price. ^[4][6]

Licensing is the biggest single lever

The terms you grant can move the price more than the data itself. The clearest observable pattern in Dayda marketplace deals: exclusive licensing typically commands a 3–5× premium over a comparable non-exclusive license. Buyers pay for scarcity they can control; an exclusive license removes competitors from their training moat.

Real price benchmarks by data type

The ranges below are Dayda's own observed numbers across marketplace listings and deals, original market data you won't find aggregated anywhere else. They're anchors, not offers: the number that ultimately clears is negotiated against a specific buyer's use case. Figures assume reasonable volume, documented consent, and at least baseline annotation.

A worked example: pricing a support dataset

Take a concrete asset, the kind of dataset Dayda actually brokers. A fintech startup is winding down with 890,000 multi-turn support conversations, resolution-status labels on about 340K of them, and fully documented customer consent. Here's the reasoning a professional buyer-facing process runs.

• 1Name the highest-value use case. The strongest buyers are AI labs (RLHF / support-AI fine-tuning) and enterprises building customer-support assistants. That use-case value, not collection cost, sets the ceiling.
• 2Anchor to comparables. Non-exclusive support-transcript deals cluster around $45K–$90K for this volume. Start there.
• 3Apply the annotation uplift. 340K conversations carry resolution labels, ready-made RLHF signal worth roughly a +20–30% uplift over raw transcripts.
• 4Apply the domain premium. Finance is scarcer than generic support, adding another +15–25%.
• 5Decide licensing. Selling non-exclusive, perpetual stays near the anchor. A buyer who wants exclusive, perpetual pays a 3–4× multiplier.
• 6Prove legal cleanliness. Documented consent plus de-identification unlocks top-tier buyers who pay a premium for zero legal risk. ^[4][6]

How to benchmark your own data in 6 steps

You don't need an appraiser. You need a reproducible process. Run these six steps and you'll have a defensible range, plus the confidence to defend it in a negotiation.

• 1Inventory the asset. Count tokens (for text) or rows (for tabular/conversations). Document schema, fields, formats, volume-by-year, and every bit of metadata you hold.
• 2Score the seven drivers honestly. Rate volume, quality, domain scarcity, metadata, recency, licensing, and legal cleanliness as Low, Medium, or High. Be honest; a buyer will find the weaknesses anyway.
• 3Name your 2–3 most plausible buyer use cases. RLHF, fine-tuning, RAG retrieval, analytics? Different use cases support very different prices.
• 4Pull comparables. Use the Dayda benchmarks above plus your own research on recent deals in adjacent verticals.
• 5Model 2–3 licensing scenarios. Non-exclusive vs. exclusive, perpetual vs. time-limited. This is where the range really opens up.
• 6Pressure-test behind an NDA. The only true price is what a real buyer pays for a 1–5% anonymized sample. Until buyers see it, every estimate is just an estimate.

Why provenance and compliance lift (or kill) value

Legal cleanliness is a gate, not a bonus. A buyer who can't verify that you lawfully hold and can transfer the data will walk away at any price, or demand a discount so steep it erases the value. The two regimes that matter most for startup data are the GDPR (for personal data with EU/UK touchpoints, consent and lawful basis are prerequisites to transfer) ^[6] and HIPAA (for clinical data, where a certified de-identification path is what makes the asset licensable at all). ^[10]

For clinical data specifically, HIPAA's de-identification standard, the Safe Harbor removal of 18 identifiers or an expert-determination path, is what turns a hospital's or health-tech startup's records into a transferable training asset. ^[2] A certified, documented de-identification process immediately opens a much larger, more sophisticated buyer pool.

Negotiation tactics that extract maximum value

Valuation sets the range. Negotiation decides where you land. These are the tactics Dayda sees move deals upward in practice:

• Anchor with the exclusive number, not the non-exclusive one. Starting high-but-defensible frames the whole conversation around the premium scenario.
• Use exclusivity as a structured escalation. Offer non-exclusive first, then let the buyer tell you exclusivity is worth it to them; they'll name a premium themselves.
• Create competition. Getting NDAs in front of 2–3 qualified buyers with a limited window reliably produces better offers than a single buyer does.
• Sell the outcome, not the rows. Frame value in terms of what your data does for the buyer's product, better RLHF, fewer hallucinations, domain accuracy, not tonnage.
• Keep a sample behind an NDA. Full access destroys scarcity before a deal closes.
• Price metadata and annotations separately. Annotated/labeled fields are a distinct premium line, not a rounding error.

The 7 valuation mistakes founders make

• 1Pricing per row or per token as if it were a commodity. Scalper-style unit pricing leaves enormous licensing value on the table.
• 2Giving exclusivity away for free. Most first-time sellers offer everything to close faster and lose a 3–5× premium.
• 3Leading with volume. A bigger but noisier corpus is worth less than a smaller, well-annotated one.
• 4Selling to a single buyer. Without competition you get a take-it-or-leave-it conversation, not a negotiation.
• 5Letting collection cost anchor the ask. Your cost is irrelevant; the buyer's replacement cost and use-case value set the price.
• 6Skipping legal prep. Missing consent or provenance documentation is the single most common reason a promising sale dies.
• 7Letting the dataset sit. Data decays and markets move. The wind-down window is short, and today's AI data demand is historically high.

Valuation is a process, not a formula

There's no magic number for how much your data is worth, but there's a rigorous way to find the right range, and it's entirely within your control. Inventory the asset, score the seven drivers, name the buyer use cases, compare against real benchmarks, model your licensing options, and pressure-test behind an NDA. Do that and you'll negotiate from a position of strength instead of guessing.

The market backdrop only strengthens the case for acting now. Public data is projected to run out within the next several years, and proprietary, human-generated datasets are among the scarcest and most defensible assets in AI. ^[2] If you're winding down or pivoting, that data isn't a cleanup task. It may be your single most valuable remaining asset.